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I am grateful for the opportunity to participate in this important meeting. It
comes at a time of great controversy over biotechnology, and I hope that the
audience and speakers can identify some areas of agreement.
For those of you who are not familiar with the Center for Science in the
Public Interest, it is a nonprofit consumer-advocacy organization that, since
1971, has focused on food safety and nutrition. Our activities have touched
most Americans lives, because in 1990 we led the efforts to win passage of laws
mandating the Nutrition Facts food label and a federal definition of “organically
grown” foods. We are supported largely by the 850,000 subscribers to our
Nutrition Action Healthletter, along with foundation grants. We do not accept
funding from government or industry.
Though CSPI sometimes has been accused of being anti-everything in the
world of food, from fettucine Alfredo to olestra to McDonald’s french fries, we
have a decidedly middle position on genetically engineered foods. We believe
that, if used properly, engineered crops could greatly benefit farmers,
consumers, and the environment. They hold the promise of increased yields,
reduced use of pesticides, lower costs, and better nutrition. Indeed, some of
those benefits already have been partly realized. But, if misused, biotech foods
could cause great harm.
Biotechnology is reaching a crossroads, where public opposition may become
so great that no farmer, food manufacturer, or retailer will want to market a
food with biotech ingredients. The biotech industry, by and large, has insisted
that genetically engineered foods are sufficiently regulated and perfectly safe.
That posture simply is not flying in the age of StarLink™ corn, mad cow
disease, and the Internet.
Critics are generating many questions about biotechnology, ranging from
accusations of potential health and ecological catastrophes to monopolization
of the seed industry by a few companies. Currently, genetically engineered
crops benefit primarily the seed and chemical companies and farmers, not
consumers. When benefits are enjoyed by one party, but possible risks are
borne by another, it is a formula for suspicion. In such an environment, it
behooves those who hope to realize the potential benefits of biotechnology to
address valid concerns, debunk red herrings, and build long-term public
confidence. One key step would be to establish strict rules to protect the
environment and ensure safety and choice to consumers.
Before I address the concerns, let me emphasize that farmers, the environ-
ment, and environmentalists should draw some measure of satisfaction from
existing benefits of genetically engineered crops and the absence of known
health and environmental problems.
• The widespread use of Bt cotton has dramatically reduced the use of
organophosphate pesticides. According to the National Center for Food
and Agriculture Policy, Bt cotton in 1999 resulted in 2.7 million pounds
less use of chemical insecticides and 15 million fewer applications of
insecticides. Cotton production increased by 260 million pounds per year,
and net revenues increased by an estimated $99 million. That is a
tremendous boon to farmers and presumably to non-target species,
including insects and the birds and other organisms that feed on them.
• Herbicide-tolerant soybeans reduced weed-control costs by $216 million in
1999, and reduced herbicide applications by 19 million. Although biotech
soybeans have led to a great increase in the use of glyphosate herbicides,
those herbicides appear to be much safer than some that they replace. No-
till farming, which herbicide-tolerant crops encourage, should reduce soil
erosion.
• Bt corn saved an estimated 66 million bushels of corn from European corn
borer in 1999. Also, Bt corn should have lower levels both of insect
damage and of some mycotoxins.
• Genetically engineered papayas provide Hawaiian farmers an effective new
means of coping with the papaya ringspot virus, which has been
decimating crops.
Bt cotton in 1999 resulted in 2.7 million pounds less
use of chemical insecticides and 15 million fewer
applications of insecticides.
Other crops could be providing similar benefits:
• Bt sweet corn and potatoes could dramatically reduce insecticide use.
• Apples resistant to fire-blight bacteria could benefit farmers in the
Northeast.
• Herbicide-tolerant sugar beets could reduce soil erosion.
However, farmers and processors are unwilling to plant or accept those crops
for fear of consumer backlash.
SAFETY CONCERNS
From the point of view of the consumer, the key question about biotech foods is,
“Are they safe?” Many consumers are leery because they do not know what
biotech foods are, and the term “genetically modified” sounds scary.
To date, of course, biotech foods have not caused any known health problems
whatsoever. Though still in its infancy, biotechnology’s record of safety is
reassuring. To be honest, though, it probably would be impossible to identify
many long-term problems, such as immunotoxicity, carcinogenicity, or
neurotoxicity, with current testing procedures.
One of the obvious concerns is whether engineered foods might cause
allergic reactions. Known allergens are easy to identify. However, if a protein to
which people have had only limited exposure were introduced into foods, one
could not state definitively that it would not cause any allergic reactions.
Another concern is that levels of naturally occurring toxins in plants might
be increased. Again, known toxins are easy to assay. But it is not inconceivable
that a genetically engineered food would display a novel toxicity, such as by
activating a “silent” gene or unexpectedly altering a metabolic pathway. Finally,
some scientists have speculated that there is a very small risk that transgenic
foods could cause a catastrophe: anything from being carcinogenic to
introducing prions causing something like Creutzfeldt-Jakob disease. While
speculative, those concerns indicate the need for a rigorous, but not suffocating,
regulatory scheme, including appropriate testing standards.
Herbicide-tolerant soybeans reduced weed-control costs by




While consumers may focus on safety, transgenic crops raise diverse environ-
mental questions. Whether it is the effect of Bt corn on monarch butterflies and
other non-target organisms, the spread of genetically engineered characteristics
to wild relatives, or the development of pesticide resistance in insects or weeds,
GM crops deserve the closest scrutiny. After all, the self-propagating nature of
living organisms—be they fish or wheat—means that once a problem occurs, it
might be uncontrollable. The United States Department of Agriculture (USDA)
and the Environmental Protection Agency (EPA) are responsible for anticipat-
ing and preventing environmental problems caused by GM crops. But serious
questions have been raised about the rigor of those agencies’ scrutiny and
judgment. For example, last year a committee of the National Academy of
Sciences (NAS) identified numerous ways in which the system should be
strengthened. And last March an EPA Science Advisory Panel concluded that
data requirements for the effects of Bt corn on non-target insects were not
complete, leading the EPA to ask companies for new studies.
The USDA recently established an Advisory Committee on Agricultural
Biotechnology to provide independent advice on environmental concerns, and
commissioned the NAS to conduct an ongoing review of its (USDA’s) regulatory
process. Those committees should help guide the USDA cautiously into the
future and increase public confidence in agricultural biotechnology.
REGULATION – SAFETY
Most Americans, I believe, are open to biotechnology, but want assurances that
the foods are safe and that crops and other organisms will not adversely affect
the environment. We need to upgrade the regulatory system to respond to these
concerns.
The Food and Drug Administration (FDA) has long considered genetically
engineered plants to be “substantially equivalent” to conventional varieties,
relying upon a voluntary consultation process to address any safety concerns.
The Food and Drug Administration (FDA) has long
considered genetically engineered plants to be “substan-
tially equivalent” to conventional varieties, relying upon a
voluntary consultation process to address any safety
concerns. Although that process has not resulted in any
health concerns, it invites criticism.
Although that process has not resulted in any health concerns, it invites
criticism. After all, the process largely transpires behind closed doors and does
not result in formal approval. In contrast, the FDA has a mandatory, albeit
secret, process for approving transgenic animals—such as genetically
engineered fish—and the EPA has a mandatory, relatively open, process for
evaluating transgenic pest-protected plants, such as Bt corn. The USDA, too,
has a relatively open process for considering whether new crops may adversely
affect agriculture.
The FDA recently proposed a mandatory review process to replace its current
voluntary system for evaluating GM crops. Importantly, the new process would
ensure that all new food crops are scrutinized. Also, the new process would be
open to public scrutiny, with most company documents being placed on the
public record. However, because the FDA has not provided formal safety-testing
guidelines, and because companies propose safety tests to the FDA, the process
gives the appearance of being driven by industry’s decisions. Moreover, the new
review process still would not result in formal approval. Instead, the FDA
would say, “We have no further questions.” While that approach might not
result in any safety questions, it would still invite the accurate criticism that
transgenic crops are not formally approved in the United States, and that,
unnecessarily, diminishes public confidence.
Because the FDA has been unwilling to argue that it has the authority to
formally approve all biotech foods, Congress should pass a law to mandate that
it does so. New legislation would distinguish transgenic organisms from
existing categories, such as “generally recognized as safe” substances, incidental
additives, or food additives. Last year, Congressman Dennis Kucinich and
Senator Richard Durbin introduced different bills to establish a formal approval
process. Those bills provide good starting points for debate. Passage of such
legislation could reduce public controversy.
New legislation should require each proposed new GM crop or animal to be
supported by a petition to the FDA. Importantly, such petitions would be public
documents, enabling any concerned party to scrutinize the data and provide
input to the agency. The end point would be the publication of a formal
approval in the Federal Register. That notice would explain the agency’s
thinking and respond to any concerns submitted by outsiders to the agency.
In contrast, the FDA has a mandatory, albeit secret,
process for approving transgenic animals—such as
genetically engineered fish
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Although food and seed companies support “mandatory consultations,”
currently they object to a formal approval process. They contend that the FDA
could take years to make decisions. That problem might be soluble simply by
requiring that a decision be made within a specified period of time. If necessary,
user fees or ordinary appropriations could provide the FDA with adequate
staffing to make timely decisions. Industry also fears that legislation on biotech
approvals might be saddled with all sorts of amendments. Frankly, I fear the
same thing: that industry would use the bill as a vehicle for achieving other
goals. I would hope, though, that voluntary agreements and astute management
of the bills would restrict the content to a mandatory approval process.
Representative Kucinich’s bill incorporates several other sensible measures. It
would ban common or severe allergens from biotech foods, phase out
antibiotic-resistance marker genes, and have the NAS’s Institute of Medicine
evaluate FDA’s system for evaluating biotech foods. One question that should be
studied carefully, as the NAS recommended last year, is whether sub-chronic or
chronic toxicity animal-feeding tests should be conducted on transgenic foods.
New legislation also should fund research at the National Institutes of Health or
the FDA to develop better means of predicting allergenicity.
The StarLink™ episode revealed two additional problems. First, farmers and
seed producers apparently lack the ability to ensure that corn—or other
crops—grown for feed will not appear in food. Hence, as Kraft Foods and
others have recommended, the FDA and EPA should not approve biotech crops
for animal feed if they are not also approved for human food. Second, the FDA
and USDA lack the authority to recall products, engineered or not. Senators
Tom Harkin and Byron Dorgan have introduced legislation to give those
agencies recall authority, but that bill has not moved through Congress.
Those all are simple, sensible steps that the biotech and food-manufacturing
industries should be able to accept and, indeed, to support.
REGULATION – LABELING
The second component of an improved regulatory scheme concerns the labeling
of genetically engineered foods. Concerns about labeling range from those
about allergies to ethics to the environment.
In response to environmental groups, the European Union, Australia and
several other countries are requiring labeling of foods containing genetically
engineered ingredients. The FDA says that it is not obligated to require foods
containing biotech ingredients to state “Contains Genetically Engineered
The FDA and EPA should not approve biotech crops for
animal feed if they are not also approved for human food.
Ingredients,” or “GM,” somewhere on the label. Instead, the FDA recently
defined a voluntary labeling scheme that it believes will be useful to consumers.
It has described situations in which terms like “does not contain genetically
engineered ingredients” may be used on labels. Consumers concerned about
GM foods would then have a choice. I hope that the FDA will anticipate future
developments by providing guidance to ensure that labels claiming that a
transgenic product offers benefits—such as “reduces the use of pesticides” or
“increases nutritional value”—are honest. Overall, the FDA’s labeling guidance
represents a small improvement, but does not satisfy those who want
mandatory labeling. And even the FDA admits that very few foods, other than
those grown organically, will sprout labels.
Some critics hope that GM labeling will be the kiss of death for engineered
foods and agricultural biotechnology. But it may be that the public is simply not
going to have confidence in biotechnology if companies are not more open
about their use of transgenic ingredients. Indeed, the FDA’s own focus-group
research revealed intense feelings around the marketing of genetically
engineered foods without special labeling.
To better understand the public’s interest in biotech labeling and how
consumers might react to it, CSPI recently commissioned a national telephone
survey of about 1,000 American adults.
First, two questions found that 62% to 70% of people say they would like
engineered foods to be labeled. Those percentages, of course, are similar to
many previous surveys indicating fairly broad support for biotech labeling.
We wanted to get beyond that first question and understand attitudes about
labeling in greater detail.
The survey found that as the amount of the engineered ingredients in a food
decreased, so does the desire for labeling. If labeling were required, 61% of
those surveyed said that a whole food, such as a tomato, should be labeled. If a
major ingredient, such as the wheat in Wheaties, was engineered, 53% said that
that should be labeled. The percentage favoring labeling dropped to 42% for a
minor ingredient, such as corn starch in a frozen dinner and to 38% for a food
Some critics hope that GM labeling will be the kiss of
death for engineered foods and agricultural biotechnology.
But it may be that the public is simply not going to have
confidence in biotechnology if companies are not more
open about their use of transgenic ingredients.
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containing soy oil that does not contain any other engineered material. Thus, if
labeling were required, well under half of people wanted labeling when only
small amounts of, or no, genetically modified material was present.
One thing about surveys that ask whether people want more information is
that people indicate a desire for just about any piece of information about food
production. Thus, based on two questions in our survey, 76% wanted labels to
disclose the spraying of pesticides, and 66% wanted information on genetic
engineering. But 43% wanted label statements on foods grown with practices
that cause soil erosion, and 40% wanted the use of hybrid corn to be disclosed.
It could be that most Americans know little about food production and are
suspicious of any process or term they do not understand. One may interpret
our survey as indicating that 40%, not 0%, should be considered the baseline
when asking people if they want something on labels about growing practices.
Another question gave people four choices and asked them which one they
would add to food labels, if they could add just one. Almost twice as many
people, 31%, wanted labeling for pesticide residues as genetic engineering, 17%.
Considerably fewer people, 8%, wanted imported wheat to be labeled, and
7% wanted processing contaminants to be declared.
Several questions indicate that support for labeling is not as deep as appears
at first glance. We asked people how much extra they would pay for their
family’s food to have labels declare that foods were genetically engineered.
About 50% of the people whose top labeling priority was genetic engineering,
or who said that engineered foods should be labeled, would pay either nothing
or only $10 per year for that labeling. One in four respondents said they would
pay $50 per year or more for labeling. A small group of consumers, 12%, would
pay $250 a year or more to get labeling; those are the hard-core proponents of
labeling. Thus, although most consumers may desire labeling of GM foods,
relatively few appear willing to pay additional costs for that information. Of
course, some people might want labeling, but feel that someone else — namely
the food and seed industries — should bear the costs.
To better inform the public and decision makers, an agency like USDA’s
Economic Research Service should estimate the costs of different forms of GM
labeling.
We next explored how people interpret label statements. About one-third of
respondents believed that foods labeled “contains genetically engineered
ingredients” are less safe or not as good as foods without labels. There was little
difference if the term “biotechnology” was used instead of “genetically
engineered.” Conversely, about one-third of respondents believed that foods
labeled “does not contain genetically engineered ingredients” are better than
foods without such a label. Thus, if, as appears to be the case, there is no
difference in safety or quality between conventional and GM crops, many
consumers apparently would be deceived by labels that state “genetically
engineered” or “not genetically engineered.”
Those perceptions about safety, quality, or other matters carried over into
buying behavior. Only about 40% of respondents said they would buy foods
made with genetically engineered ingredients. It did not matter whether the
foods were transgenic fruits and vegetables or processed foods that contained
only minor ingredients that came from engineered crops. Clearly, considering
the public’s current views, no food manufacturer would market foods
containing engineered ingredients if they had to put a statement on the label.
We also asked people if they would buy foods bearing other labels.
Interestingly, while only 43% of the respondents said they would buy foods
labeled “genetically engineered,” about the same percentage said they would
buy foods labeled as having been sprayed with pesticides, treated with plant
hormones, or made from hybrid corn. Apparently, people have apprehensions
about any unusual and suspicious-sounding statements on labels.
One thing our survey did not examine is the reaction to different kinds of
labels. We left to the imagination of the respondents the prominence of the GM
label on food packages. It would be worth exploring how differently people
might perceive the term “contains genetically engineered ingredients” on the
front of the package, the term “genetically engineered” embedded within the
ingredient statement, and a small “GM” symbol somewhere on the front of the
package. Our only finding in this area was that when GM labels stated “reduces
pesticide use,” the percentage of people who thought those foods were safer
jumped from 7% to 21%. Still, about 30% of people continued to believe that
the GM food was not as safe as other foods that might have been sprayed with
pesticides.
If foods are to be labeled, Congress should give the FDA a clear mandate,
because the FDA will not require such labeling on its own. In any case, though,
whether label statements are mandatory or voluntary, such statements should
not lead people to think that a food made with genetically engineered
ingredients is inferior, or that a food made without genetically engineered
ingredients is superior.
Labeling is a “catch-22” problem for industry. As long as engineered foods are
not labeled, people will contend that the public’s right to know is being short-
changed and will criticize government and companies for hiding that
information. If engineered foods were labeled, many people would not buy
them, and so companies, not wanting to lose sales, will not market engineered
foods with a label. Considering how negatively the public views the term
“genetically engineered,” I think that industry needs to be candid with
consumers about the benefits and pitfalls of the technology. The food industry
could lessen suspicions if it mounted a full-scale advertising campaign
depicting hundreds of packaged and restaurant foods that contain ingredients
from engineered crops. Those ads could explain the apparent safety and the




Probably the most likely problems concerning biotech products pertain not to
consumer health but to ecological disruption. One major concern is that while
the EPA stipulates that certain crops, such as Bt corn, be accompanied by
refuges of conventional crops, no agency polices and enforces such critically
important requirements. That must be corrected. Also, the NAS report on pest-
protected plants made numerous specific recommendations, ranging from
regulating viral coat proteins under the Federal Insecticide Fungicide and
Rodenticide Act (FIFRA) to improving inter-agency coordination. All of those
recommendations should be implemented.
The USDA is charged with ensuring that new crops do not become pests. But
experience suggests that environmental reviews by the Animal and Plant Health
Inspection Service (APHIS) have underestimated the potential for significant
problems resulting from Bt corn’s impacts on lepidopterans, from the weediness
potential of herbicide-tolerant canola and virus-protected squash, and from the
need for pest-resistance-management planning for Bt crops.
Despite the millions of acres planted with GM crops, APHIS has never
prepared a full environmental impact statement (EIS) for any of the GM crops
that it has approved. Full EISs would have led to better analysis and mitigation
for any remaining questions.
To summarize: now is the time, while agricultural biotechnology is still
young, for Congress and regulatory agencies to create the framework that
would maximize the safe use of these products, bolster public confidence in
them, and allow all of humankind to benefit from their enormous potential.
OTHER CONCERNS ABOUT AGRICULTURAL BIOTECHNOLOGY
Aside from effects on the public’s health and the ecosystem, agricultural
biotechnology raises many other concerns. While it is impossible to explore
each of these matters in detail, I will touch on various measures that would
boost public confidence and help ensure that biotechnology is used wisely and
productively.
Underlying many of the attacks on biotechnology is the question of whether
a handful of giant companies will soon control the world’s major crops and the
technology itself. The briar patch of patent rights that affects Golden Rice
exemplifies the extent to which private industry (and, in some cases,
universities) has gained control over the technology. Also, it is clear that
commercial interests focus on the largest and most profitable crops in the
developed world—and then only on applications that are profitable—rather
than those the primary purpose of which is to protect the environment.
To bring the greatest benefits to the most people, it is essential that the
industrial nations sponsor more basic and applied research to ensure that new
methods and products are in the public domain. Government-sponsored
research also should address the needs of small farmers, consumers, and the
environment, as well as the so-called minor crops, which may not be so minor
to the people who grow and eat them, whether in the industrial or developing
world. To ease the regulatory-cost burden for small businesses, universities, and
researchers, government could waive certain fees. For example, the USDA’s
current IR-4 program, which helps register certain low-profit uses of pesticides,
could be expanded to support “orphan” biotech applications. Furthermore, we
need to expand aid programs to train scientists in developing countries, fund
research stations, and help those nations build a regulatory structure to
anticipate and prevent possible problems. In some of those countries, the need
for careful regulation is particularly acute, because ancestral cultivars grow side
by side with commercial varieties, making it difficult to prevent gene pollution
of the traditional genotypes.
Organic farmers in the United States have justifiable fears that pollen from
biotech farms will pollute their crops, possibly rendering them non-organic
under the law. If an organic farmer saved his or her seed from year to year, it is
easy to see how even 1% contamination per year by neighboring biotech crops
would soon significantly decrease the purity of the seed. While the definition of
“organic” does not specify allowable contamination levels, anything over a few
percent would certainly begin to jeopardize the premium that organic food
commands. Organic farmers also fear that insects will develop resistance to Bt
toxin. While that concern was always present due to the use of that natural
insecticide by organic farmers themselves, the widespread planting of Bt corn
and cotton increases tremendously the possibility that pests will become
resistant. I do not pretend to have the solutions to these tough problems, but
they deserve careful attention. Buffer zones, compensation by seed companies,
and other measures should be developed to protect the integrity of organic
foods, without raising their prices even further.
BEYOND BIOTECHNOLOGY
Let me conclude by noting that many critics of biotechnology are opposed to
any and all of its applications, apparently regardless of its benefits. Advocates
should not fall into a similar trap of thinking that biotechnology is the answer,
regardless of the question. Genetic engineering is not the only tool in the
agricultural toolbox. Conventional breeding and non-transgenic applications
To bring the greatest benefits to the most people, it is
essential that the industrial nations sponsor more basic
and applied research to ensure that new methods and
products are in the public domain.
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of biotechnology offer tremendous opportunity. We should also note that
production agriculture, biotech or not, suffers from real problems. Many
farmers are losing money and declaring bankruptcy. Many more would, were
it not for huge government bailouts. Both advocates and critics of genetic
engineering should recognize that the wisest course of action would be
simultaneously to follow several paths to satisfy our food needs, making use
of genetic engineering, conventional methods, and organic or sustainable
approaches. Many farmers are discovering that sustainable agriculture,
including organic farming—based on smaller farms, diverse crops, and natural
means of pest control—may be just as profitable, or even more so. Their input
costs may be lower, while their crops may command premium prices in the
marketplace.
There are no big chemical or seed companies or government subsidies to
support this approach to agriculture. Hence, my final recommendation would
be for agricultural schools, the USDA, and state departments of agriculture to
conduct more research and provide greater technical and financial assistance to
farmers who want to get off the agribusiness treadmill.
Q: You mentioned the organic farmers and risks of contaminations. They
have indicated only 100% organic, or zero percent contamination, is acceptable.
Is it reasonable to think that anyone in today’s agricultural environment in the
United States can produce soybeans that are zero percent transgenic?
A: It may be possible in some areas of the country to produce 100% non-
transgenic soy, but organic food does not have to be 100% organic. The Food
and Drug Administration and the United States Department of Agriculture have
called for an identity preservation system, with affidavits and so on, indicating
that the intent of the farmer and the food system is to keep these products as
pure as possible, but the government is not insisting that they be 100% organic
with regard to pesticides or transgenics or other contamination. Food will not
be declared non-organic if one kernel of Bt corn is in the crop.
Many critics of biotechnology are opposed to any and all
of its applications, apparently regardless of its benefits.
Advocates should not fall into a similar trap of thinking
that biotechnology is the answer, regardless of the ques-
tion. Genetic engineering is not the only tool in the
agricultural toolbox.
Q: To what degree would you say previous interactions of consumers . . .
[inaudible]
A: I think the bigger factors in consumer perceptions are the very effective
criticisms by the opponents, who have created symbols that are very easy to
understand: a dead monarch butterfly, for instance, or the term frankenfood,
which are powerful means of communication. The advocates of biotechnology
have not developed equally effective symbols—“fewer farmers poisoned by
pesticides” for example. Proponents have not waged an effective campaign to
educate the public. It amazes me that so few are talking about the benefits from
reducing insecticide use, or herbicide use. The critics cannot bear to acknowl-
edge that there are some benefits from biotech foods, even though these people
are critical of pesticide use—they’ve been campaigning against them since
Rachel Carson was around. So, the critics aren’t talking about it, and, on the
other hand, the companies can’t talk about it because some of them make
pesticides. For these companies, it is not a plus for pesticide sales to go through
the floor. And the trade associations, which represent industry’s lowest common
denominator, cannot talk about these benefits. Somebody must contribute to
the debate facts that demonstrate benefits to the public at large, maybe not as
consumers, but out of concern for the environment. This is needed in Europe
also. The advocates of biotechnology, the companies, the professors, consumer
groups, etc., need to go to Europe and talk about how Europeans’ insistence on
non-biotech crops means that the American ecosystem will be more polluted,
that more farmers will be harmed, and that more non-target insects and other
species will be killed.
Q: With reference to your remarks on sustainability, were you implying that
there is no role for genetic engineering in sustainable agriculture?
A: No. Genetic engineering can contribute to sustainability. Twenty years
from now, organic farmers may be clamoring for genetically engineered crops
that are beneficial and safe, and fit into their systems; they are not inconsistent.
Q: A key problem in Europe is that organic agriculture is striving for 100%
zero tolerance of genetic engineering. Don’t you think that organic agriculture
has to come to terms with the fact that genetic engineering is part of agricul-
ture, therefore they have to find a way to accommodate a threshold as they are
doing for pesticides and herbicides?
A: They don’t have to. If you are against genetic engineering, you’ll want zero
tolerance. It’s a political decision. In the United States, a decision has been
made that the test for organically grown foods will not be chemical; instead, it
will be a paper trail. The government has not indicated a percentage, neither
0.1% nor 5%. The assumption is that it is a small fraction, and court cases may
be needed at some point to decide what the percentage will be. The government
has said minimal contamination—a little is okay.
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Q: Something we have learned in the food industry is that you can sell an
advantage that is directly linked to the product, but it is difficult to sell
advantages that are far upstream in the process. You mentioned that the biotech
industry has failed to draw attention to decreased pesticide use. In my opinion,
even if they produce pesticides and GM crops that are resistant to these
pesticides, if the biotech industry is unable or unwilling to articulate these
advantages it will be extremely difficult to change the minds of the consumer.
A: Yes, it is pathetic that the industry itself can’t do it. It could be that’s life
and we will not have genetically engineered foods for a period of years. The
biotech industry needs to wake up. Companies like Monsanto that don’t market
most chemicals—obviously they market Roundup—that are adversely affected,
need to speak out, and maybe the academic community and regulators need to
talk to them and try to knock some sense into their heads. But ultimately, the
technology may be lost for some years, or its use will be restricted to feed grains
or fiber crops, like cotton, that don’t enter the food chain.
Q: Does the CSPI provide informational hand-outs or brochures on educating
the public on issues such as labeling?
A: We are just beginning to do this. We have had a couple of articles in our
newsletter, the Nutrition Action Healthletter, which reaches 800,000 people, and
we have had a couple of op-ed articles in the Wall Street Journal and other
newspapers. We are beginning to reach out to the public via the usual Website,
but it has to be much bigger than CSPI alone. We are hoping to serve as a
nucleus around which groups that have a reasonable attitude may coalesce and
call for sensible regulation of genetically engineered crops, portraying them
neither as evil nor as a panacea. The big money lies with the food industry and
the seed and chemical companies, and any mass-media efforts must come from
them. If they are unwilling to mount a significant effort, they may see their
market shrivel. The academic community could speak out more clearly,
particularly in regard to calls for a better regulatory system. The public has had
sufficient reassurances from professors who consult for the biotech companies
and are less than totally believable—but they would have greater credibility if
they called for tighter regulatory controls. Especially people at the University of
Illinois because Senator Durban is very influential and very sensible.
